MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. I’m listening to the conference call right now and will update you later today when ... Read more The post scPharmaceuticals ($SCPH) Being Acquired – Large Premium appeared first on Deep Knowledge Investing.
